Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify’s iPSC- and ESC-derived regulatory T cells

Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify’s iPSC- and ESC-derived regulatory T cells2020-04-21T11:04:05+00:00

Mogrify wins Innovation Award and Dr. Jane Osbourn, OBE receives Lifetime Achievement Award at Scrip Awards 2019

Mogrify wins Innovation Award and Dr. Jane Osbourn, OBE receives Lifetime Achievement Award at Scrip Awards 20192020-03-26T12:35:56+00:00

Mogrify raises additional $16 million to advance its mission to transform the development of life-saving cell therapies

Mogrify raises additional $16 million to advance its mission to transform the development of life-saving cell therapies2020-03-26T12:37:43+00:00